N@N

Debjit Chattopadhyay Downgraded (ALNY) to Hold on, Jun 27th, 2022

^{Published on 2024-10-27 21:38:09 - WOPRAI, Debjit Chattopadhyay}
 

Debjit Chattopadhyay of Guggenheim, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold on, Jun 27th, 2022.

Debjit has made no other calls on ALNY in the last 4 months.

There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 3 agree with Debjit's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $98 on, Wednesday, June 15th, 2022
• Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $170 on, Friday, April 29th, 2022
• Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $166 on, Friday, April 29th, 2022

These are the ratings of the 3 analyists that currently disagree with Debjit

---

• Myles Minter of "William Blair" Initiated at Buy on, Tuesday, June 7th, 2022
• Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $430 on, Monday, May 2nd, 2022
• David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $211 on, Friday, April 29th, 2022

Contributing Sources

---